Navigation Links
Novel Plans Of FDA To Monitor Safety Of Medical Devices

The Food and Drug Administration of U.S has chalked out a seemingly fool proof plan that will ensure stringent standards of safety //and efficiency of medical gadgets that are used as implants in the bodies of millions of patients requiring them for various medical reasons.

The several medical devices available in the market today in the U.S accounts for a whopping $ 80 billion annually generating phenomenal profits for big firms such as Medtronic, Johnson & Johnson, Boston Scientific. Unlike medicines which are tried and tested through rigid series of clinical tests before they are introduced into the general market, gadgets are scrutinized for flaws attributed to defects in design or manufacturing defects of individual units, more often after they are introduced into the market.

The FDA now intends to revamp this system by insisting on having encoded script for identification on every piece of gadget manufactured by a firm to scrutinize and detect malfunctions and side effects that could be caused by the device. They also plan to revamp computer databases where complaints and problems faced by clients are registered and submission of complaints of defects on paper will be completely reverted to digital processing and expand present real time based data base which collects information from several hundreds of hospitals that would hopefully track safety problems faster using more trained professionals.

The FDA has reported that they also plan to revolutionize their communication systems with each other and with the general public.

The proposed changes come after debates over the past one year following the recall of many such gadgets primarily related to cardiac diseases of the heart such as cardiac stents which prevent major blood vessels from collapsing, and implantable defibrillators that prevent those with weak hearts from dying.

These proposed changes have of course its share of criticism with many experts frown ing down on these revamp plans as they say that these plans does not really address the risk and they add that without involving a large number of patients to volunteer for controlled experiments which itself is too risky.
MST
'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... PORT RICHEY, Fla. (PRWEB) , ... February 27, 2017 , ... ... use disorder, but concern for women who become dependent on opioid painkillers has fallen ... among female patients, compared to a 237% increase in fatal overdoses in male populations.(1) ...
(Date:2/27/2017)... ... ... Orange County dentist, Dr. A. Rassouli, comments on the new ... bacteria in plaque infect the gums and other tissues supporting the teeth. Treatment typically ... SRP, and can include surgical therapies if the condition has led to significant damage. ...
(Date:2/27/2017)... ... ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the International Lyme and Associated ... Disease Control ( CDC ) and Infectious Diseases Society of America (IDSA) dismiss any ... into a single volume a compelling argument that the disease does exist in his ...
(Date:2/27/2017)... Francisco, CA (PRWEB) , ... February 27, 2017 ... ... center for hair transplantation therapy, is proud to announce a new informational post ... hair therapy procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of ... concern over nerve agents and the deadly use of chemical weapons. Many questions exist ... how even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 2017   Royal Philips (NYSE: ... in health technology, today announced 510(k) clearance from ... market its ElastQ Imaging capability, further expanding the ... ElastQ Imaging enables simultaneous imaging of tissue and ... the diagnosis of various liver conditions. With ElastQ ...
(Date:2/27/2017)... 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... focused on tissue protection, repair and regeneration, today ... Ltd., received a positive response from the U.S. ... for RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 ... Thymosin beta 4 ("Tß4") as the active pharmaceutical ...
(Date:2/27/2017)... , Feb. 27, 2017  CTI BioPharma Corp. (CTI BioPharma) ... Adam Craig , M.D., Ph.D., as President and Chief Executive ... March 20, 2017. Dr. Craig succeeds Richard Love , ... the company,s Board of Directors.  Dr. Craig has over 20 ... both the US and Europe . ...
Breaking Medicine Technology: